POPULARITY
7 episodes with dry eye disease
5 episodes with dry eye disease
5 episodes with dry eye disease
3 episodes with dry eye disease
3 episodes with dry eye disease
2 episodes with dry eye disease
2 episodes with dry eye disease
2 episodes with dry eye disease
2 episodes with dry eye disease
Viola Kanevsky, OD, was born in the former Soviet Union, but after a family “adventure” they settled down in New York City when she was a child. Like most optometrists, she worked in several modes of practice early on, but today, she owns a specialty pediatrics practice in Manhattan. She loves seeing children and considers it “play time” rather than an exam. Her advice for working with kids is to think outside of the box, be patient, and follow their lead. She shares her tips on how to fit infants and small children with specialty contact lenses (psst... The secret is keeping the parent calm). Her practice does not take vision plans or medical plans (other than Medicare) because she wants to be able to prescribe what is best for each patient. She also discusses her family's passion project called “The Ship of Tolerance.” You may have seen her witty posts and comments as a group expert in ODs on Facebook, but now it's time to get to know Dr. Viola Kanevsky better. Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Mile Brujic, OD, FAAO, is an international optometric educator with over 2000 lectures given to date. For 22 years, he has been with the same practice, where he's now one of the partners. He shares with Dr. Joseph Allen how he entered the speaking world by developing dry eye and contact lenses CE courses for opticians. His keys to success include putting in the hard work to truly master the content and a commitment to getting raw, honest feedback and taking it to heart to improve. Working with industry partners, he's had the opportunity to conduct research and consult on cutting-edge innovations in eye care, making him a better clinician as a result. Personally, he finds immense strength in his partnership with his wife, as they've grown together over the years to support each other's professional pursuits. His current passion is his work on Optometric Insights with Dr. David Kading to help educate and inspire students to greater career enjoyment and success. Lastly, he implores all optometrists to be dues-paying members of their national and state optometric associations to create an even more powerful and unified profession. Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Listen as a dry eye panel of experts discuss the challenges of dry eye disease (DED) diagnosis and treatment and how Reichert-SBM's Dry Eye Suite of products have impacted their practice and patients.Featuring:Dr. Justin SchweitzerDr. Lisa MaclaughlinDr. Marc Bloomenstein
Dr. Cory Lappin knew as an optometry student that he found his passion for dry eye, cornea and anterior segment disease as his fellow students commonly complained about symptoms of dry eye. After completing his residency at Cincinnati Eye Institute, he was fortunate to join Phoenix Eye Care and Dry Eye Center of Arizona, where he was mentored by the legendary Dr. Art Epstein. Since publishing the Ultimate Guide to Dry Eye, Dr. Lappin has continued to pursue his passion for writing and educating, putting an emphasis on scientific literacy. Dr. Lappin's passion for the advances in ocular surface disease diagnosis and treatment is contagious. Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Mark Schaeffer, OD, FAAO, was born into eyecare and worked every job possible in the family practice before going to optometry school after earning an undergrad degree in marketing. As part of MyEyeDr, Dr. Schaeffer is the Clinical Excellence Captain, helping onboard new doctors in the group. He firmly believes that optometrists need to prioritize their expertise and invest in “chair time” with each patient to provide education and create value. Listen in as he and Dr. Allen discuss their approach to patient care, helping them understand the “why” behind their recommendations. Finally, they discuss how excited they are about the numerous innovations and new technologies in eyecare and how they are improving patient care. This episode is sponsored by Bausch + Lomb Blink™ NutriTears® Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
OKYO Pharma Ltd CEO Gary Jacobs joined Steve Darling from Proactive to share additional key findings from the Phase 2 clinical trial evaluating the safety and efficacy of OK-101 (0.05%) ophthalmic solution in patients with dry eye disease (DED). This trial involved 240 patients in a randomized, double-masked, placebo-controlled study. OK-101, developed using a membrane-anchored-peptide technology, is a novel long-acting drug candidate designed to treat dry eye disease. It has shown anti-inflammatory and pain-reducing efficacy in mouse models of dry eye disease and corneal neuropathic pain. Jacobs highlighted that the findings include a statistically significant and durable reduction in ocular pain and a statistically significant improvement in Tear Film Break-Up Time throughout the study, which is a clinically important endpoint. Additionally, multiple symptomatic improvements were observed through both data obtained from patient clinic visits and daily symptom diaries. Jacob explained that OK-101 targets a receptor called Chemerin 23, present on both immune and nerve cells, including those in the spinal cord and ocular nerves. Preclinical animal studies indicated that OK-101 could reduce neuropathic pain, which can be particularly severe and debilitating in affected patients. The company is preparing to launch a Phase II trial for OK-101 specifically targeting neuropathic corneal pain. This trial will be a placebo-controlled, randomized study involving 48 patients diagnosed with ocular nerve damage through confocal microscopy, with top-line data anticipated by mid-2025.The significance of this development is underscored by the lack of FDA-approved treatments for neuropathic corneal pain, a condition recognised by the National Organization of Rare Diseases. The upcoming trial aims to fill this therapeutic gap, potentially offering relief to patients suffering from this excruciating condition. #proactieinvestors #okyopharmalimited #nasdaq #okyo #GaryJacob, #DryEyeDisease, #OK101, #ClinicalTrials, #NeuropathicPain, #OcularHealth, #PharmaceuticalResearch, #FDAApproval, #MedicalInnovation, #HealthUpdates, #BiotechNews, #PatientCare, #PhaseIITrail, #TopLineData, #Chemerin23, #NerveDamage, #RareDiseases, #PlaceboControlled, #EyeResearch#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
In today's episode of the Future of eye Care Series, we discuss the opportunities within dry eye management with dry eye implementation expert Michelle Schnabel. Key Takeaways:The dry eye disease market will grow from $6 Billion to over $7 Billion in the next five years. While many optometrists have expanded dry eye management within their practice, there will be so many more patients to treat from now into the future.Michelle believes there are three different levels of dry eye disease management today in practice. Where does your practice fall?Full Service Practice - Leverages variety of tools and equipment to both diagnose and actively manage the disease v. just the symptoms. They retain all patients in their practice and create the opportunity to develop referral relationships with others.Referral - This practice refers primarily based on symptoms. They may manage some of the symptoms but refer for more active treatments.Shared Care - This practice diagnoses and actively manages dry eye patients but does not have full treatment options and therefore will share the care with other practices in the area that may have additional treatment modalities.Successful implementation of dry eye management in clinic depends on your why. Beginning with the why for adding services, communicating it frequently among the team, and finding ways to measure and track success.What Michelle is Reading:Start With Why by Simon SinekPractice Advantage Reading List** Don't miss out on an extra $10 rebate for all commercial VSP Eye Exams this year! Earn up to an additional $55,000 in 2024 just by taking great care of patients. Visit www.pecaaexamrebate.com now!**
Dr. Whitley wears many hats as a practicing optometrist at Virginia Eye Consultants, where he also serves as Director of Professional Relations and Education and Regional Medical Director. Since graduating around the same time Restasis hit the market, Dr. Whitley has been at the forefront of recent research and innovation in the diagnosis and treatment of dry eye disease. In fact, he's been involved in more than a dozen clinical trials and enjoys lecturing to share his key learnings. Dr. Whitley shares his dry eye workup including patient assessment and various testing he may or may not do based on symptoms. When treating dry eye disease, he feels it's vital to know all the options and be able to set clear expectations for patients. Lastly, the doctors discuss some of the exciting new treatment options in the pipeline. Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
On this episode, we examine the management of dry eye disease and allergic conjunctivitis. It is important that pharmacists and nurses understand the appropriate use of the medications and when to seek a more thorough work-up. This session seeks to explore these topics, focusing on how this information can best be incorporated into daily medical practice. Learning Objectives: a. Recognize and distinguish between dry eye disease symptoms and allergic conjunctivitis. b. Discuss the appropriate use of pharmacologic therapies available for treating both conditions, including eye drops, antihistamines, and other relevant medications. c. Understand the importance of proactive management to mitigate long-term complications. d. Identify more severe signs and symptoms that may warrant a referral to a specialist. Cole and I are happy to share that our listeners can claim ACPE-accredited continuing education for listening to this podcast episode! We have continued to partner with freeCE.com to provide listeners with the opportunity to claim 1-hour of continuing education credit for select episodes. For existing Unlimited (Gold) freeCE members, this CE option is included in your membership benefits at no additional cost! A password, which will be given at some point during this episode, is required to access the post-activity test. To earn credit for this episode, visit the following link below to go to freeCE's website: https://www.freece.com/ If you're not currently a freeCE member, we definitely suggest you explore all the benefits of their Unlimited Membership on their website and earn CE for listening to this podcast. Thanks for listening! We want to give a big thanks to our sponsor, High-Powered Medicine. HPM is a book/website database of summaries for over 150 landmark clinical trials. You can get a copy of HPM, written by Dr. Alex Poppen, PharmD, at the links below: Purchase a subscription or PDF copy - https://highpoweredmedicine.com/ Purchase the paperback and hardcover - Barnes and Noble website We want to give a big thanks to our main sponsor Pyrls. Try out their drug information app today. Visit the website below for a free trial: www.pyrls.com/corconsultrx If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below: www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
Dr. Joshua Davidson has a clear passion for eye care and his patients as an optometrist, which has led him to help solve their problems through innovation and product development. He has become a national expert on Dry Eye Disease and specialty contact lenses. While seeing 30-50 dry eye patients a day and discussing the importance of drinking water, he realized there was a hole in the market. He pulled together a few doctors to formulate a drink mix specifically to help dry eye patients. He discusses the entrepreneurial journey with Dr. Joseph Allen and shares the lessons he learned along the way … from idea to product development to bringing it to market. Learn more about the Dry Eye Drink here: https://dryeyedrink.com/ Key Moments 1:59 How Dr. Davidson got into optometry 3:56 Where/how Dr. Davidson practices optometry today 5:29 His path to focusing on specialty lenses 8:07 The origins and development of the Dry Eye Drink 12:52 Collaborating with five doctors on product development 14:15 Bringing a new product to market 20:40 Flavor preferences. Does orange Dry Eye Drink taste like Tang? 22:22 Adding a night-time version to Dry Eye Drink 24:44 The research behind melatonin 28:22 The importance of having a mentor as an entrepreneur 30:25 The need for front-line doctors to create products that improve patients' lives 33:30 Where the best ideas come from 35:49 Future research on the Dry Eye Drink 37:10 Thoughts on uniform licensing nationally Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
In this episode, Ayesha spoke with H. B. Pierre Simon Jr., MBA, Vice President, Global Head of Marketing, Sight Sciences, about the evolving field of eye care. Sight Sciences is focused on developing and commercializing innovative solutions for eye diseases like glaucoma and dry eye disease to transform care and improve patients' lives.Among some of Sight Sciences devices and technologies include the OMNI® Surgical System, a minimally invasive glaucoma surgery (MIGS) device indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma (POAG), the world's leading cause of irreversible blindness. The company's other notable product is the TearCare® System, which has FDA clearance for localized heat therapy in adult patients with evaporative dry eye disease due to meibomian gland dysfunction (MGD), the leading cause of dry eye disease.Pierre has been in the eye care industry for almost two decades. Prior to Sight Sciences, he was at Alcon for 15 years in roles with increasing responsibility, including Senior Product Manager, Global Franchise. Pierre is also a life influencer and two-time best-selling author. His latest book is entitled ‘Down Thru Love,' a story about the journey of a young man born with Down syndrome.In the episode, Pierre discusses some important considerations in the development of innovative new treatments for eye conditions like glaucoma and dry eye, such as working with patients and doctors and having an awareness of both current and future needs. Hear more about Pierre's work at Sight Sciences and also as an author and speaker. For more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
After getting her first pair of glasses at age 12 and seeing the individual leaves on trees for the first time, Pam knew she'd be an optometrist. As an adult, she struggled with her own dry eyes, which led her to focus on helping others alleviate their symptoms. Today, Dr. Pam Theriot advocates for 4 simple steps for a daily hygiene routine: Hydrate, Harmonize, Heat, Heal. Listen in to hear how Dr. Theriot is sharing her knowledge with the masses through her clinic, her book and now the metaverse: https://theomniverse.city/dry-eye-metaverse/Learn more about Dr. Pam TheriotFind her book "Alleviate Dry Eye" Key Moments 0:48 Dr. Allen introduces Dr. Pam Theriot 2:05 How Dr. Theriot found optometry 3:17 Moving around as a military spouse 5:38 Creating a dry eye clinic 8:43 The path to self-publishing 13:48 Preparing patients prior to initial consultation 14:40 post-appointment follow-up communication 16:43 Dr. Theriot's 4 simple steps for daily eye hygiene 18:11 Recommending nutritional supplements with Omega fatty acids 20:57 Dry eye technology and treatments 23:03 The future dry eye treatments 25:48 The first dry eye clinic in the Metaverse 33:07 Eye care should be part of your daily health care Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Join Dr. Bilkhu in her discussion with Dr. Mila Ioussifova about taking a holistic approach to dry eye disease. Dr. Ioussifova is a residency-trained optometrist with a private practice in Portland, OR. She is dedicated to helping patients with dry eye disease and offers advanced dry eye therapies in her practice. Dr. Mila Loussifova recently studied human nutrition and functional medicine at the University of Western States and is in the process of becoming a Certified Nutrition Specialist. She is passionate about treating dry eye disease while incorporating nutritional and lifestyle changes. The Four Eyes Podcast is brought to you by YoungOD Connect Learn more about Dr. Mila Ioussifova on Instagram Learn more about The Institute for Functional Medicine
Michael Cymbor, OD, FAAO, radiates with a passion for optometry, especially when it comes to the connection between exercise, muscle mass, and ocular health. He discusses the research and how different types and intensities of exercise should be considered for different conditions. He knows each patient will have a different reaction to “you should exercise more,” so he makes sure to meet them where they are regarding their exercise routine. Dr. Cymbor truly enjoys mentoring optometry students, as well as tapping into his creative side, which led to the creation of hid video: “Night of the Living DEModex.” Key Moments: 2:49 Dr. Cymbor's path to a career in optometry 5:13 What brought Dr. Cymbor to State College, PA (“Happy Valley” … home of Penn State University) 6:20 The story behind his video: “The Night of the Living Demodex” 11:46 Dr. Cymbor's passion for glaucoma care and how it led to The Glaucoma Institute in partnership with his ophthalmologist partner 14:55 The types of optometrists who gravitate towards a glaucoma specialty 19:09 Current views on glaucoma research 21:08 Dry eye and ocular surface disease 27:30 Finding your sense of purpose 30:00 The value and importance of mentorship 33:10 Exercise and ocular health 38:09 How muscle mass impacts blood sugar levels 41:29 Exercise and eye pressure as it relates to glaucoma 44:05 Research into exercise and stress management 48:10 “Meeting patients where they are” regarding exercise 51:55 The Pickleball effect 54:00 The importance of earlier intervention to improve outcomes Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Do you believe you don't need an eye exam if you have perfect vision? It's time to bust that myth! I've invited my very own optometrist, Dr. Jesse Camen to explore why regular visits to the optometrist are crucial for everyone. Dr. Camen is a California licensed optometrist who was influenced into the field at a young age after witnessing the impact that a local optometrist had on her brother's education. Today, she's not just an eye specialist; she has a special focus on Sports and Performance Optometry and also manages Dry Eye Disease.We'll answer the big question: How often should you get your eyes tested? Dr. Jesse will highlight the crucial role of yearly eye exams, what exactly she looks for during these check-ups and the symptoms that should have you seeing an optometrist immediately and ways to preserve your eye health proactively. Plus, we'll get into the hot topic of blue light glasses – are they just a trend or a true eye-saver?Whether you wear glasses, contact lenses or fall into the perfect vision category, this episode has something for you. Join us as we dive into everything you need to know about eye exams and eye health. Tune in to the episode NOW!Head to the Show Notes: https://health-uncovered.captivate.fm/episode7To request a consultation with Dr. Mercedes head to https://www.uppercervicalsd.comLet's be Instagram friends: @drmercedescookFollow Upper Cervical Chiropractic San Diego on Instagram: @uppercervicalsandiegoPS. Are you loving the podcast? I'd appreciate it if you could leave a rating and review for my show! This helps me support other healthcare providers who want to think outside of the box to get their patients answers and for those struggling on their health journey so they can move forward on their healing journey more confident than ever. And make sure you hit 'FOLLOW' so you don't miss out on any new episodes when they drop every Thursday. Happy listening!
If you've ever dreamed of owning your own optometry private practice, developing a niche, inventing a new product, or giving back to the community, then take some time to be inspired by Dr. Janelle Davison's story. Like many others, she found her path to optometry by speaking to her own optometrist then finding a mentor who was doing everything she wanted for her own life – owning a practice, growing a family, teaching, and loving life as a doctor. In 2010, She cold opened her own practice in Georgia and has never looked back. She and her business partner, who is also her husband, invented PARADEYEM software to help ODs take control of optical revenue, increase efficiency, and reduce costs. Today, Dr. Davison is known as the “Dry Eye Mentor” and enjoys customizing treatment plans for each patient by listening to their needs and addressing their goals. As a natural extension to treating dry eye disease and based on a suggestion from a patient, Dr. Davison has evolved her clinic to provide full-service ocular aesthetics with an in-office spa. Finally, her true passion is mentoring high school students. She and her sister (a dentist) created S.C.O.R.E. INC. to “pay it forward” and encourage minority high school students to pursue careers in dentistry, optometry, or ophthalmology, as less than 6% of doctors in the US are African American or Hispanic American. Discover more about Dr. Janelle Davison and her passions:https://brillianteyesvisioncenter.com/https://dryeyeinstituteofga.com/https://thedryeyementor.com/https://wescore.org/https://paradeyem.com/ Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Torn between math and medicine as an undergrad, Shalu Pal shadowed 10 different types of doctors to figure out which one was truly happy but didn't find the joy she was seeking. Then, she walked into her optometrist's office and heard laughter coming from patients, staff and doctor. At that point, she knew she had found her path forward. After optometry school in Southern California, Dr. Shalu Pal first specialized in specialty lenses at her residency in Oklahoma, which led to expanding her interests to dry eye disease, ocular aesthetics, and myopia management. Today, she focuses on her “why” of happiness as the owner of a thriving practice in Toronto, Canada, by fostering a warm, joyous environment for her staff and patients. Discover her strategies for building a robust clinic with the best doctors in each specialty focused on improving the lives of their patients. The doctors dive into current treatments for mastering myopia management as well as upcoming technologies in the pipeline. Dr. Pal also enjoys sharing her love for optometry with students, new grads and her colleagues through lecturing and co-editing the Mastering Myopia newsletter. Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
**How are we doing?? Click here to complete a brief, 2-minute survey.** We get to learn from Dr. Rolando Toyos, author of “The Life and Times of a Sports Ophthalmologist” and founder of the Sports Ophthalmology Society of the Americas. Dr. Rolando Toyos is a cataract and refractive surgeon in Memphis, Tennessee, and founder of the nationally acclaimed Toyos Clinic. Before medical school, Dr. Toyos was a high school teacher and basketball coach. He received his medical degree at the University of Illinois and completed ophthalmology residency at Northwestern University and Chicago Children's Hospital. Dr. Toyos is the inventor of the intense pulse light (IPL) procedure for Dry Eye Disease. Dr. Toyos has worked with athletes in the NFL, NBA, MLB, and World Boxing Association, including close connections with the Memphis Grizzlies, Seattle Mariners, and Memphis Redbirds. Dr. Toyos has authored numerous books, including “The Life and Times of the Sports Ophthalmologist.” The Life and Times of the Sports Ophthalmologist "Antonio Margarito's license approved"
The FDA and CDC greenlight updated COVID-19; prescription drug for dry eye disease now available; head-to-head study comparing Skyrizi to Stelara for Crohn disease; the REMS program has been updated for IBS treatment Lotronex; and the FDA cracks down on companies selling unnaproved eye products.
Dr. Julie HelmusDoctor Eye HealthFluoreSCENE Media Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
The Importance of Eye Care When You Have An AutoimmuneAired Friday, June 30, 2023 at 4:00 PM PST / 7:00 PM ESTSo my attention was piqued when I was asked recently, “We brush our teeth and moisturize our skin daily, but what do we do for our eyes?” I had to be honest and say I hadn't really thought about it…I do know that Rheumatoid Arthritis and Lupus are just two autoimmune diseases that can affect your eyesight and lead to vision loss if left unchecked… so I asked my thought-provoking questioner to sit down with us and chat about eye care and autoimmune—' that questioner' being the co-founder of MyCorneaCare.com and ophthalmic surgeon Dr. Jovi Bopari.Dr. Jovi shares simple changes that relieved him from his struggle with eye problems. We covered a lot in our time together, including Dry Eye Disease and the importance of eye care even as we sleep—especially when you have an autoimmune condition. He also gives us the answers to…• When it's just' seasonal' dry eye, Dry Eye Disease, or autoimmune-driven dry eyes?• Do the blue-light-blocker glasses work, and how about sunglasses?• How body inflammation, familiar to those with autoimmune, can lead to eye dryness, sensitivity to light, blurred vision, and other eye ailments,• And the surprising sleep habits we all need to protect our eyes while we sleep and much more…More About Our Guest:Ophthalmologist and Ophthalmic Surgeon Dr. Jovi Boparai is passionate about educating patients and the world about the importance of personal eye care and Dry Eye Disease.The daily habits of increased screen time for work and personal use, seasonal allergies, contact lens use, and notable side effects of several oral medications have led to a rise in Dry Eye Disease. It's estimated that between 16 million and 49 million Americans have dry eyes. Now that's not all autoimmune related, but that 16-49 million is about 5-15% of the US population.Learn more about Dr. Boparai and CorneaCare, the company he co-founded to make eye health more accessible, at https://mycorneacare.com/.#DrJoviBoparai #Dryeyes #UnderstandingAutoimmune #EyesAndAutoimmune #AutoimmuneHour #EyeCare #Wellness #SharonSayler* Your host is not a doctor or medical professional. All professionals presenting on the show only share opinions and do not give medical or other advice. Seek your own professional care and guidance if you have questions or concerns. The information presented in this interview cannot substitute for the advice of your physician or other trained medical, healthcare, or other professionals. This show is not intended to diagnose, prevent, or treat autoimmune diseases or other conditions or illnesses. The information provided on UnderstandingAutoimmune.com, Life Interrupted Radio.com, and The Autoimmune Hour is for educational purposes only. It is not a substitute for your own medical, legal, or other professional advice and care.All materials on YouTube@UnderstandingAutoimmne, The Autoimmune Hour (Show), and UnderstandingAutoimmune.com are the copyright of Competitive Edge Communications. For more videos and podcasts, visit https://www.UnderstandingAutoimmune.com.Visit the Autoimmune Hour show page https://omtimes.com/iom/shows/autoimmune-hour/Connect with Sharon Sayler at http://lifeinterruptedradio.com/Subscribe to our Newsletter https://omtimes.com/subscribe-omtimes-magazine/Connect with OMTimes on Facebook https://www.facebook.com/Omtimes.Magazine/ and OMTimes Radio https://www.facebook.com/ConsciousRadiowebtv.OMTimes/Twitter: https://twitter.com/OmTimes/Instagram: https://www.instagram.com/omtimes/Linkedin: https://www.linkedin.com/company/2798417/Pinterest: https://www.pinterest.com/omtimes/
So my attention was piqued when I was asked recently, “We brush our teeth and moisturize our skin daily, but what do we do for our eyes?” I had to be honest and say I hadn't really thought about it... I do know that Rheumatoid Arthritis and Lupus are just two autoimmune diseases that can affect your eyesight and lead to vision loss if left unchecked... so I asked my thought-provoking questioner to sit down with us and chat about eye care and autoimmune—'that questioner' being the co-founder of MyCorneaCare.com and ophthalmic surgeon Dr. Jovi Bopari.Dr. Jovi shares simple changes that relieved him from his struggle with eye problems. And we cover a lot of eye care tips in our time together, including Dry Eye Disease and the importance of eye care even as we sleep—especially when you have an autoimmune condition. He also gives us the answers to...• When it's just' seasonal' dry eye, Dry Eye Disease, or autoimmune-driven dry eyes? • Do the blue-light-blocker glasses work, and how about sunglasses? • How body inflammation, familiar to those with autoimmune, can lead to eye dryness, sensitivity to light, blurred vision, and other eye ailments, • And the surprising sleep habits we all need to protect our eyes while we sleep and much more...More About Our Guest: Ophthalmologist and Ophthalmic Surgeon Dr. Jovi Boparai is passionate about educating patients and the world about the importance of personal eye care and Dry Eye Disease. The daily habits of increased screen time for work and personal use, seasonal allergies, contact lens use, and notable side effects of several oral medications have led to a rise in Dry Eye Disease. It's estimated that between 16 million and 49 million Americans have dry eyes. Now that's not all autoimmune related, but that 16-49 million is about 5-15% of the US population. Learn more about Dr. Boparai and CorneaCare, the company he co-founded to make eye health more accessible, at https://mycorneacare.com/Please share with family and friends: https://UnderstandingAutoimmune.com/DrJovi-2023* Your host is not a doctor or medical professional. All professionals presenting on the show only share opinions and do not give medical or other advice. Seek your own professional care and guidance if you have questions or concerns. The information presented in this interview cannot substitute for the advice of your physician or other trained medical, healthcare, or other professionals. This show is not intended to diagnose, prevent, or treat autoimmune diseases or other conditions or illnesses. The information provided on UnderstandingAutoimmune.com, Life Interrupted Radio.com, and The Autoimmune Hour is for educational purposes only. It is not a substitute for your own medical, legal, or other professional advice and care.All materials on YouTube@UnderstandingAutoimmne, The Autoimmune Hour (Show), and UnderstandingAutoimmune.com are the copyright of Competitive Edge Communications. For more videos and podcasts, visit https://www.UnderstandingAutoimmune.com.
Colac optometrist Leigh Plowman chats about Optometry Australia's Dry Eye Guide and the recent announcement that Victorians now have access to a new chronic severe dry eye disease treatment listed on the Pharmaceutical Benefits Scheme.
In this episode, Ayesha talked about the FDA approval of the first topical gene therapy for the treatment of a rare skin condition. Krystal Biotech's Vyjuvek is a topical gene therapy that has been approved for the treatment of wounds in patients with the rare, often debilitating skin disease dystrophic epidermolysis bullosa (DEB). It's the first treatment for the rare disease. Hear more about DEB and Vyjuvek in this episode.Ayesha and the team also discussed the FDA approval of Bausch + Lomb's first prescription drug for the treatment of dry eye disease. The drug, called Miebo, is also the first treatment that targets tear evaporation, which is a leading cause of dry eye disease. Hear more about the drug and its approval in the show.Read the full articles here:Vyjuvek Gets FDA Nod as First Topical Gene Therapy for Rare Skin DiseaseMiebo Approved as First Dry Eye Disease Treatment to Target Tear EvaporationFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks Instagram: @Xtalks Facebook: https://www.facebook.com/Xtalks.Webinars/ LinkedIn: https://www.linkedin.com/company/xtalks-webconferences YouTube: https://www.youtube.com/c/XtalksWebinars/featured
Jeff Varanelli, OD, FAAO, Dipl. AAO, ABO, ABCMOFrom his early days in laser surgery to working with an ophthalmologist, Dr. Varanelli found his passion for the anterior segment to help his patients improve their overall eye health. For more than a decade, Dr. Varanelli has been an enthusiastic educator on all things related to dry eye and ocular surface disease. He is now taking the lead in Neurotrophic Keratitis (NK). Beyond herpetic eye disease, learn about other causes of NK and how to detect it, classify stages, and treat it more proactively. The doctors also discuss how they find ways to work within the system to advocate for the patient, even though insurance hurdles can be extremely frustrating for both patient and practitioner. Hosted by Joseph Allen, OD, FAAO, Diplo ABODr. Joseph Allen may be most well known as @DoctorEyeHealth on YouTube where he shares tips and education about eyes and vision for the general public. Now, with his Eye Give a Damn! Podcast series, Dr. Allen goes in depth with his colleagues to discuss the challenges and opportunities facing optometry. From finances, private equity and insurance headaches to specialty lenses and the frontlines of scope expansion, hear from leading optometrists and industry friends. They sit down with Dr. Allen to share their personal journeys in eye care, expertise and passions. Discover why so many of us give a damn about the future of optometry and the variety of ways we can drive our industry forward! Eye Give a Damn hosted by Dr. Joseph Allen is produced by FluoreSCENE Media.For more information on Dr. Joseph Allen visit https://doctoreyehealth.com/Visit https://odcommunity.com/ to learn more about FluoreSCENE Media.
Obada Subei with The Brain and Eye Institute Danielle Remington with Ophthalmic Surgeons and Physicians and Patient Carly Norton The Brain and Eye Institute is Arizona’s only Neuro-Ophthalmic service provider accepting new patients. It is directed by Dr. Obada Subei. The Brain and Eye Institute's mission is to provide the entire state of Arizona with […] The post Obada Subei with The Brain and Eye Institute Danielle Remington with Ophthalmic Surgeons and Physicians and Patient Carly Norton appeared first on Business RadioX ®.
Jackie Garlich, OD, FAAO, and Leslie O'Dell, OD, FAAO, are joined by Mila Ioussifova, OD, FAAO, to discuss the links between lifestyle, nutrition, and dry eye disease. Dr. Ioussifova shares her recommendations for talking to patients with dry eye about how proper nutrition to support their gut microbiome can positively affect their ocular surface health.
We talk about "Eyesthetics" with guest appearances from Drs. Kerry Salsberg, Jordan Friedman, Michelle Baron. Dry Eye Hive is a live dry eye show where "dry eye docs talk shop." Come to engage in a casual townhall style talk show every other Tuesday at 8:30pm ET. Learn from doctors in the trenches making it happen in their offices. Sponsors: Dry Eye RescueZocularEye Help You
In this final episode of “International Perspectives on Dry Eye Disease,” Laura Periman, MD (United States); Jose Gomes, MD (Brazil); and James Wolffsohn, OD (United Kingdom) hear from a patient about her journey with dry eye. What snags did this patient encounter during the diagnosis and treatment of her disease—and what can it tell us about how we can improve patient care?
Which ocular conditions and elements of ocular history might place patients at risk of dry eye disease? In the second episode of the miniseries “International Perspectives on Dry Eye Disease,” Laura Periman, MD (United States), invites Christopher Starr, MD (United States), and Fiona Stapleton, OD (Australia), to share their observations about the intersection of dry eye disease and ocular comorbidities.
We often think of dry eye disease (DED) as merely an ocular disorder. But what about the systemic conditions that might dictate the terms of DED? In the debut episode of the miniseries “International Perspectives on Dry Eye Disease,” Laura Periman, MD (United States), invites Mile Brujic, OD (United States), and Victor Perez, MD (United States), to discuss how often-overlooked systemic disorders may actually be driving or exacerbating DED in some patients. This editorially independent podcast is supported with advertising by Novartis.
About Dr. Natalie Chai:Dr. Natalie Chai founded the Dry Eye Centre at Precision Eye Care when she joined the team in March of 2020. Dr. Chai attended the University of Alberta before receiving early acceptance to Pacific University College of Optometry in Forest Grove, Oregon, where she earned her joint Bachelor's Degree in Vision Science and Doctor of Optometry. Prior to practice, she successfully completed the Canadian Assessment of Competence in Optometry (CACO) as well as the National Board of Examiners in Optometry (NBEO) in the United States. Her practice is focused on Dry Eye Disease, Myopia Management, and Specialty Contact Lenses – these are specialties that are under-represented and under-used in the Edmonton region. Dr. Chai is happy to serve the community, co-manage with other health professionals, and help educate and empower her colleagues who seek to do the same.
KSQD 10-05-2022: All about dry eye disease -- diagnosis and treatments; Rotavirus vaccine helps protect babies from developing type 1 diabetes; Can hypnosis help me reduce waking up at night to pee? How does the uterus not contract prematurely during pregnancy? A review of deep magnetic brain stimulation for depression and other brain conditions; Steroid injections are associated with rapid hip degeneration, but causality is not clear; Platelet rich plasma for joint pain is very popular now
Our abrupt change to a lifestyle on screens means we're learning about the consequences as we live them. Dr Alex Muntz is an Ophthalmology research fellow at the University of Auckland, he speaks to Jesse.
The doctors are joined by John Huemoeller, CEO of AXIM Biotechnologies, who is a biotech leader on a mission to innovate the eye care industry with a new one-of-a-kind test that helps to diagnose people with Dry Eye Disease. As we know, Dry Eye Disease has been very difficult to diagnose due to its symptoms and many causes, it is estimated to impact at least 6.8% of the U.S. population. AXIM's new MMP-9 test, which is the first rapid quantitative tear test for Matrix metalloproteinase-9 (MMP-9), an inflammatory biomarker for Dry Eye Disease, is set to change the future of DED diagnostics. Tune in to listen to learn about the new technology and find more information about it at AXIMEYE!
In this episode of To the Point, Jackie Garlich, OD, FAAO, and Leslie O'Dell, OD, FAAO, are joined by Kelly K. Nichols, OD, MPH, PhD, FAAO, who shares her knowledge of novel dry eye therapies in the pipeline. Dr. Nichols also discusses what optometrists can look forward to in the next couple of years.
Interview with Bita Asghari, OD, FAAO, Associate Director of Clinical Education for BostonSight, Needham Heights, MA. Contact lens expert, Dr. Bita Asghari, discusses how scleral contact lenses intersect with other dry eye therapies to bring patients maximal comfort. Find out where sclerals can fit into your treatment strategy.
On Health Suites, the neverending exposure to digital screens have very real eye health consequences - among them, dry eye disease, which may sound rather mild, but can be a serious condition! Melissa Hyakspeaks to Professor Louis Tong, Principal Clinician Scientist & Head of the Ocular Surface Research Group, @ Singapore Eye Research Institute (SERI), and Senior Consultant, Corneal & External Eye Disease Department, @ Singapore National Eye Centre (SNEC) and Dr Pat Lim is Head, TCM Ophthalmology Department, Chief Physician and Board Vice Chairman, Singapore Chung Hwa Medical Institution (SCHMI),to find out more. See omnystudio.com/listener for privacy information.
Patrick Tresserras Former CEO & founder, Avizorex Pharma (acquired by Aerie in 2019)In this episode of the OIS Podcast, Dr Robert Rothman is joined by Patrick Tresserras, former CEO & Co-founder of Avizorex Pharma which was sold to Aerie in 2019. Dr. Rothman hones in on Patrick's unique ability to identify promising academic assets to address unmet medical needs. Patrick's first start-up Avizorex was founded in 2013 based on a technology originated from research conducted by Professor Carlos Belmonte at the Institute of Neurosciences in Alicante, Spain. The science involved temperature-sensitive neurons in tear film regulation. Patrick convinced Professor Belmonte to partner with him and then went on to secure financing and assemble a team to transform Avizorex's lead candidate AVX-012 (a selective TRPM8 agonist eye drop) from an early stage preclinical asset into a novel Dry Eye Disease product candidate. Following positive phase 2 data, Patrick successfully structured an acquisition deal with Aerie just prior to the Covid-19 pandemic. We also learn about Patrick's next venture, another ophthalmic startup “Innerva” that is developing INE-01, an ocular formulation of a PIEZO2 antagonist as the active ingredient for treatment of ocular surface pain. Innerva's lead asset INE-01 being developed under IP license from University of Tennessee Research Foundation.Listen in…
On this episode, we discuss dry eye disease (also known as keratoconjunctivitis sicca). We give some basic background information including pathophysiology and signs/symptoms. We then compare and contrast the various artificial tear products based on the information from "Artificial tears potpourri: a literature review" (PubMed ID below). We then discuss the roles of ophth cyclosporine, ophth lifitegrast, and nasal varenicline. PMID: 25114502 Thanks for listening! If you want to support the podcast, check out our Patreon account. Subscribers will have access to all previous and new pharmacotherapy lectures as well as downloadable PowerPoint slides for each lecture. You can find our account at the website below: www.patreon.com/corconsultrx If you have any questions for Cole or me, reach out to us on any of the following: Text - 415-943-6116 Mike - mcorvino@corconsultrx.com Cole - cswanson@corconsultrx.com Instagram and other social media platforms - @corconsultrx This podcast reviews current evidence-based medicine and pharmacy treatment options. This podcast is intended to be used for educational purposes only and is intended for healthcare professionals and students. This podcast is not for patients and not intended as advice or treatment.
Dr. Whitley talks about neurological dry eye with Dr. Diana Driscoll. Learn more about Parasym Plus Eyes™ and Vagus nerve support at: https://vagusnervesupport.com/parasym-plus-eyes/ Click Here to read the transcript of this podcast.
This week: big news announced in COVID-19, with the FDA stating that mixing and matching of vaccines for the booster dose is authorized. The first interchangeable biosimilar to Humira is approved. Also there's approvals for dry eye disease, pain management and opioid overdoses.
UCSF ophthalmologists review what the cornea is and why it is so important. Dr. Gerami Seitzman explores dry eye and Dr. Julie Schallhorn looks at surgeries of the cornea. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37145]
UCSF ophthalmologists review what the cornea is and why it is so important. Dr. Gerami Seitzman explores dry eye and Dr. Julie Schallhorn looks at surgeries of the cornea. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37145]
UCSF ophthalmologists review what the cornea is and why it is so important. Dr. Gerami Seitzman explores dry eye and Dr. Julie Schallhorn looks at surgeries of the cornea. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37145]
UCSF ophthalmologists review what the cornea is and why it is so important. Dr. Gerami Seitzman explores dry eye and Dr. Julie Schallhorn looks at surgeries of the cornea. Series: "Mini Medical School for the Public" [Health and Medicine] [Show ID: 37145]
In this episode of To the Point, Jackie Garlich, OD, FAAO, and Leslie O'Dell, OD, FAAO, welcome Arthur Epstein, OD, FAAO, for an in-depth discussion about dry eye disease (DED). Dr. Epstein is the cofounder of Phoenix Eye Care, heads its Dry Eye/OSD Center, and serves as its director of clinical research. Dr. Epstein shares insight into his clinical research of DED, his methods for clinical therapy, and how to manage noncompliant patients.
8 Tips for Eye Health - Dr. Paul Karpecki The Not Old Better Show Interview Series Welcome to The Not Old Better Show. I'm Paul Vogelzang and as part of our science and healthy living series, today's guest is Dr. Paul Karpecki, and we're discussing a healthy vision for all, but focused on those of us over 60. Did you know that nearly 65% of US adults complain of headaches, neck/shoulder pain, and eye strain when using digital devices, reading or doing detail work? Digital Vision Syndrome (DVS) is here and affecting thousands of us. We are at an unprecedented and critical point when it comes to the impacts of increased screen time. As our lifestyle shifts more to work from home, it puts increased pressure on near vision demands, optometrists are reporting record numbers of patients seeking a solution. In a recent study of over 110,000 patients, nearly two-thirds experienced painful symptoms often associated with eye misalignment. More than 55% of them experienced these symptoms on a daily basis. Optometrists across the nation are seeing an uptick of vision issues related to DVS including eye strain, which can lead to headaches, pain around the eyes and pain behind the eyes, as well as neck pain and other related problems. Our guest today is Dr. Paul Karpecki, who has over 20 years of experience running some of the largest dry eye clinics in the United States. Dr. Paul Karpecki is a noted educator and author of over 1000 papers on the subject of Dry Eye Disease. Dr. Karpecki currently serves as the Chief Clinical Editor for Review of Optometry, the most read journal in the profession. Please join me in welcoming to The Not Old Better Show via internet phone, Dr. Paul Karpecki. My thanks to Dr. Paul Karpecki. Hopefully, today's show will help you understand and consider the effects of Digital Vision Syndrome. Remember to check out our website for more details about Dr. Paul Karpecki and Digital Vision Syndrome. My thanks to you, my wonderful Not Old Better Show audience…be safe, and remember let's Talk About Better. The Not Old Better Show. Until next time, thanks, everybody. Check out our new show on KSCW Radio, 103.1 FM Phoenix AZ every Saturday morning at 8:15 AM/PST, and, again, you can find links to listen to the show on KSCW on our website. https://suncitywestradio.com/our-shows/
About Dr. Roya Habibi:Dr Roya Habibi is a University of California, Berkeley trained optometric doctor with a specialized focus on Dry Eye Disease and Specialty Contact Lenses. As a practicing doctor at a multi-disciplinary practice in Seattle, WA, Dr Habibi founded and serves as the Director of the Center for Eye Comfort. Within her specialty clinic, Dr Habibi is focused on treating and truly understanding dry eye disease and its effects on her patients. In clinic, she incorporates advanced diagnostic testing and empirically proven treatment options to empower her patients by helping them understand their eye conditions. Beyond her early fellowship training at Casey Eye Institute, she is inspired to provide the best in patient care in and out of the office. She strives to stay at the forefront of research regarding medically necessary contact lenses and is an Education Consultant with Valley Contax. While she provides education and advice to fellow doctors eager to learn more about scleral contact lenses, she also serves on the Scleral Lens Education Society Fellowship Committee. This committee is responsible for ensuring new doctors demonstrate expertise in the field and science of scleral lenses.Beyond the exam room, Dr Habibi spends her free time exploring the Pacific Northwest, volunteering as an ambassador for Make A Wish, and enjoying free time with her husband and two dogs.Website:https://www.drroyahabibi.com/https://www.trynot2blink.com/
The doctors are joined by Dr. Art Epstein of the Dry Eye Center of Arizona. Dr. Epstein is a wealth of knowledge when it comes to dry eye disease and he shares with us his thoughts on IPL treatment and Lumenis' new product!Visit Lumenis' website hereFollow us @visionismorethan2020InstagramFind Dr. Art Epstein hereEmail: artepstein@gmail.com
Dr. Jeffrey Nau, CEO of Oyster Point Pharma, Inc., a clinical-stage biopharmaceutical company discusses the company's lead candidate, OC-01, a nasal spray being developed to treat the signs and symptoms of dry eye disease (DED). Current treatment options are limited to eye drops, which can be difficult and uncomfortable to self-administer. The FDA accepted their New Drug Application for OC-01, which was supported by safety and efficacy results from clinical trials in over 1,000 patients with mild, moderate, or severe symptoms of DED. The U.S. launch of OC-01 nasal spray is planned for the fourth quarter of 2021, if approved by the FDA. Jeffrey Nau, PhD, MMS, President and Chief Executive Officer. Jeff has built his career on developing novel, innovative therapies for diseases of the eye, with over 15 years of experience working with biotechnology, pharmaceutical, and medical device companies. Most recently, he was VP, Clinical and Medical Affairs, at Ophthotech. Prior to that, Jeff was a Medical Science Director at Genentech working on the development of Lucentis®, a transformative drug for retinal diseases. Jeff has helped raise more than $250 million in equity for innovative startups such as Genaera Corporation, Acuity Pharmaceuticals, and NeoVista, Inc. He holds numerous patents and peer-reviewed publications. Jeff has a Ph.D. in Public Health and Epidemiology from Walden University, a M.S. in Medical Science from MCP Hahnemann School of Medicine, and a B.S. in Biology from Stony Brook University.
Did you know there's a Facebook group called Dry Eye Syndrome Support Community with over 14,000 members from across the world that advise patients on diagnosis, treatment, and mental support?Dr. Brill is religious in this community about participating and providing his professional medical advice. Many of these patients do not have access to quality dry eye care and are faced with self-diagnose and treat themselves. Dr. Brill shares his philosophy and approach to advanced dry eye care.Dr. Travis Zigler along Dr. Jenna Zigler run this community and work hard to spread awareness of proper treatments. This episode covers:No one person is the same. Until the right questions are asked, it’s hard to know exactly why you have dry eye. Have you had LASIK? Have you taken Accutane? Do you live in a dry environment? Do you drink too much caffeine? Is your diet horrible? Do you have an autoimmune condition? Are you going through menopause?Everything works well on the correct candidate.Make Insurance Verification and Pricing on Products Easy w/ This AppGet Better Lab Pricing!
About Dr. Selina McGee:Dr. Selina McGee is Founder and Owner of Precision Vision of Edmond, a boutique private practice that offers patients a wide range of optometric care via its dry eye center of excellence, specialty contact lens clinic and aesthetics suite. The practice also performs extensive pathology management and laser and minor surgical procedures. In 2018, Dr. McGee introduced eye rejuvenation services to help patients bothered by drooping eyelids or wrinkles around their eyes. In addition to her private practice, Dr. McGee is an Adjunct Assistant Professor at the Northeastern State University College of Optometry. She is a Fellow of the American Academy of Optometry and a Diplomate of the American Board of Optometry, and is Past-President of the Oklahoma Association of Optometric Physicians. She has many relationships with industry, serving on numerous advisory boards. Dr. McGee is the recipient of several awards, including the Heart of American Contact Lens Society Award, RGP Lens Institute Clinical Excellence Award and Alcon Excellence in Contact Lens Fitting Award. She has a dozen publications to her credit that have appeared in Modern Optometry, Optometry Times and Diagnostic Testing for Dry Eye Disease, among others. Dr. McGee has lectured nationally and internationally at meetings such as Alberta Optometric Association, American Academy of Optometry, SECO International, Vision Expo East and Vision Expo West among others. She earned her Bachelor of Science in Biology (where she graduated Summa Cum Laude) and Doctor of Optometry (also Summa Cum Laude) from Northeastern State University College of Optometry. Private Practice:http://www.pvedmond.com instagram: @precision_vision_edmondInstagram: @selinamcgeeLinked in: https://www.linkedin.com/in/dr-selina-mcgee-od-faao-dipl-abo-57830a7/Apps Mentioned: Think Dirty and EWG
Welcome to EyePod Bayer! In this episode, we talk about dry eye disease. eyepod@bayer.com MA-M_AFL-DK-0070-1
Walt Whitley, OD, MBA, FAAO, & Selina McGee, OD, FAAO The journey of the dry eye patient can be challenging. They often go to multiple practitioners and try several at-home remedies in an attempt to have their condition taken seriously and get some relief. In this podcast, Selina McGee, OD, FAAO, joins Walt Whitley, OD, MBA, FAAO to discuss the importance of building trust to empower dry eye patients in order to confidently take back control of their condition, as well as how EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25%*—the first FDA-approved steroid for the short-term treatment (up to two weeks) of the signs and symptoms of DED—and its AMPPLIFY® technology may benefit their patients.
Preeya Gupta, MD, & Cynthia Matossian, MD, FACS, ABES The journey of the dry eye patient can be challenging. They often go to multiple practitioners and try several at-home remedies in an attempt to have their condition taken seriously and get some relief. In this podcast, Cynthia Matossian, MD, FACS, ABES joins Preeya Gupta, MD to discuss the importance of building trust to empower dry eye patients to take back control in order to better manage their condition, as well as how EYSUVIS™ (loteprednol etabonate ophthalmic suspension) 0.25%*—the first FDA-approved steroid for the short-term treatment (up to two weeks) of the signs and symptoms of DED—and its AMPPLIFY® technology may benefit their patients.
What do windy days, masks, screen time and air conditioners have in common? They can all contribute to Dry Eye Disease (DED)! In this episode we'll look at common causes of Dry Eye Disease, tips on how to prevent dry eyes like the 20-20-20 rule, and also things to look out for when purchasing eye drops! Subscribe and Follow Us @healthanimated on Spotify, Apple Podcast, YouTube, Instagram Learn more at www.healthanimated.com Got a Question? healthanimators@gmail.com
For this week’s episode of the OIS Podcast we are sharing the “Clinical Perspective” panel discussion from our recent Dry Eye Innovation Showcase. The following KOLs delivered some fascinating strategies on addressing this massively underserved patient population. Ashley Brissette, MDAna Alzaga Fernandez, MDCynthia Matossian, MD, FACS Laura Periman, MDYuna Rapoport, MD, MPHRahul S. Tonk, MD, MBAPaul Karpecki, OD, FAAODiscussion points include:• The complexity of dry eye disease• Identifying the root causes.• Optimal treatments for varying conditions.• The importance of educating patients.Click play to get enlightened!REGISTER for our next ophthalmology conference today http://bit.ly/2yFA6cv.
This podcast was recorded on February 23rd, 2021In Episode 1 of the Xtalks Life Science Podcast, Sarah discusses a new condition called “Mask-Associated Dry Eye” and Ayesha talks about Droplet Micron, an innovative insulin needle. Tune into this episode to hear a clip from Sarah's interview with Dr. Richard Hom, optometric director at Anthem Blue Cross and Blue Shield, who talks about the impact of prolonged screen time on eye health. And hear from Anu Rajora, director of medical marketing at HTL-STREFA, the company behind the innovative Droplet Micron insulin needle, who explains why technology needs to make it easier for patients to adhere to medication schedules.Read the full articles here:Why Mask-Associated Dry Eye Won't Necessarily Boost Restasis SalesPatient Centricity in Insulin Delivery: Improving the Injection Experience with Droplet MicronFor more life science and medical device content, visit the Xtalks Vitals homepage.Follow Us on Social MediaTwitter: @Xtalks, @XtalksMedDeviceInstagram: @XtalksFacebook: https://www.facebook.com/Xtalks.Webinars/LinkedIn:https://www.linkedin.com/company/xtalks-webconferencesYouTube: https://www.youtube.com/c/XtalksWebinars/featured
In this episode Drs. Alice Epitropolous, Darrell White, and Preeya Gupta discuss how COVID has created issues in our patients with dry eye disease, mask associated dry eye, flare disease, and more.
This podcast session will explore a fresh approach to treating Dry Eye Disease (DED) and the challenges faced by your current and future patients. We are all aware that ODs play an important role as first responders in how care is delivered to DED patients. At Kala, we have discovered through extensive market research that Dry Eye Disease does not always present as continuous signs and symptoms, rather it is punctuated by exacerbating episodes or “speed bumps” called Dry Eye Flares. Join Walt Whitley, OD, MBA, FAAO in his conversation with Margie Recalde, OD, FAAO as they navigate Dry Eye Flares along with the role of inflammation in identifying patients who might benefit from a different treatment of DED.
This podcast session will explore a fresh approach to treating Dry Eye Disease (DED) and the challenges faced by your current and future patients. We are all aware that MDs play an important role as first responders in how care is delivered to DED patients. At Kala, we have discovered through extensive market research that Dry Eye Disease does not always present as continuous signs and symptoms, rather it is punctuated by exacerbating episodes or “speed bumps” called Dry Eye Flares. Join Preeya Gupta, MD in his conversation with Lisa Nijm, MD as they navigate Dry Eye Flares along with the role of inflammation in identifying patients who might benefit from a different treatment of DED.
Are you suffering from dry, irritated, red eyes? Do your eyes burn and itch after a long day? Do your eyes feel fatigued or exhausted at the end of the day? Are your eyes irritated from the air you blow into your eyes from wearing your mask? You could be suffering from Dry Eye Disease. Dr. Kambiz Silani From Beverly Hills Optometry Advanced Dry Eye Center joins us on the show to educate us on the signs, symptoms and treatments of Dry Eye Disease. Learn about the newest treatments available and how to get to the root cause of Dry Eye Disease ; including ones that could cost less than the medications you are currently taking. Understand how your diet and daily routine could be playing a role in making your DED worse. This is a very fun and educational show and guess what....It's now available on our YouTube Channel as well. Find Dr. Silani at bheyeguy@gmail.com and his website: Beverly Hills Optometry You can also book a Virtual Visit with Dr. Silani Dr. Silani Instagram Facebook Dry Eye Community Listen Today and Subscribe to The Well-Informed Patient Podcast and visit us at 1patientatatime.com
This final podcast of three dedicated to dry eye disease (DED) brings together Prof. Stefano Barabino (Italy), Prof. Marc Labetoulle (France) and Rebecca Petris (USA) to discuss DED from the patient’s perspective. Rebecca, founder of the patient organization The Dry Eye Foundation and a DED patient herself, provides insights into the impact of DED on patients’ everyday lives, describing the wide variation in individuals with DED and the patient journey from onset of symptoms to receiving effective treatment. The group also discuss the various treatments currently available for the management of DED, the concept of measuring the benefits of DED treatment in terms of impact on activities of daily living, and the importance of good communication between ophthalmologists, patients and other clinicians.
In this second podcast of a series dedicated to dry eye disease (DED), Prof. Stefano Barabino (Italy) joins Prof. Margarita Calonge (Spain) and Prof. James Wolffsohn (UK) to discuss the diagnosis and management of patients with DED. This episode covers the symptoms of DED and the diagnostic tools that can be used to identify it. The faculty discuss the importance of taking detailed clinical history, the potential for misdiagnosis, their preferred diagnostic tests and scales for use in everyday practice, new technologies that can be used to aid diagnosis of DED, and the key aspects of the condition that clinicians should explain to their patients.
In this episode, we talk about preventative eye health for 2021. We speak with Dr. Natalie Chai, an optometrist, about the impact of Covid-19 on our eyes and dry eye disease and Myopia management. We review what Optometrists can do for their patients outside from prescribing glasses and contact lenses.
No – not that apprentice. This week we had the pleasure of speaking with Todd Brady, MD/PhD turned VC/EIR turned CEO of Aldeyra back in 2012. Todd talks about how he transitioned from the lab over to the dark side back in the 90s when “Industry” was still a dirty word. Todd found his calling as a company builder who has since taken Aldeyra public and into Phase 3 trials with novel treatments for dry eye disease, allergic conjunctivitis, and proliferative vitreoretinopathy. The company is also developing other product candidates for retinal and systemic inflammatory diseases. Listen in for some words of wisdom from the real Apprentice…
Jimmy and Roya talk about wellness and how to keep yourself healthy and sane.SOURCESPractice Self Care https://www.healio.com/news/psychiatry/20200612/80-of-americans-intend-to-regularly-practice-selfcare-after-covid19-pandemicValley Contax Vision Project https://www.valleycontax.com/charity-and-giving/custom-stable-vision-project.phpIntense Pulsed Light Treatment for Dry Eye Disease Due to Meibomian Gland Dysfunction https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298157/Evaluation of the Safety and Effectiveness of Intense Pulsed Light in the Treatment of Meibomian Gland Dysfunction https://www.hindawi.com/journals/joph/2016/1910694/ Analysis of Cytokine Levels in Tears and Clinical Correlations After Intense Pulsed Light Treating Meibomian Gland Dysfunction https://pubmed.ncbi.nlm.nih.gov/28887117/ Therapeutic efficacy of intense pulsed light in patients with refractory meibomian gland dysfunction (2019) https://www.sciencedirect.com/science/article/pii/S1542012418302222#fig5 The Effects of Intense Pulsed Light on Tear Osmolarity in Dry Eye Disease (2018) https://www.longdom.org/open-access/the-effects-of-intense-pulsed-light-on-tear-osmolarity-in-dry-eye-disease-2155-9570-1000619.pdf
Conjunctivitis and dry eye disease are some of the most common conditions patients present with. They are usually benign entities that respond well to conservative measures and usually don’t require medications. However, if medications are necessary, clinicians can find a comprehensive assessment of these drugs recently published in the December 2, 2019, issue of The Medical Letter. An excerpt from this article summarizing information about conjunctivitis and dry eye disease was published in the February 4, 2020 issue of JAMA. Kathryn Colby, MD, PhD, chair of the Department of Ophthalmology & Visual Science at the University of Chicago, explains in this podcast how to treat conjunctivitis and dry eye disease.
Whitney Hauser : Hi. I’m Dr. Whitney Hauser. And welcome to Dry Eye Coach podcast. Today we’re going to be talking about tips for doctors just starting out in dry eye. So, if you’re looking for some new pearls about how to add dry eye in your practice, this may be the podcast for you. Today I’m joined by assistant professor at the University of Colorado Department of Ophthalmology, Dr. Rich Mangan. Welcome, Rich. Rich Mangan : Oh, thanks, Whitney. It’s great to be here. I appreciate it. Whitney : You bet. You bet. We’re kind of excited to get to know, you know, what you think are some of the greatest things that new practitioners, or practitioners that are just trying to bring dry eye into their practice might want to add in as they develop. So, I’m going to jump in with some questions for you… Rich : Okay. Whitney : … right off the bat. And, what are the benefits to doctors and their patients for getting started, or treating dry eye disease? You know, there’s benefits on both sides, so give us a little bit… Rich : Right. Whitney: … of your thoughts there. Rich : Right. You know, certainly, the benefit for me as a doctor in getting started was just to have a greater appreciation for the fact that ocular surface disease is in fact a real disease and not just a symptom. To be honest with you, years ago I used to hate dry eye. You know, I would go and see LASIK evals and cat evals and I was really enjoying that. And then I’d pull out a chart and it’d say dry eye and, you know, I’d just shrug in agony thinking about it. But then I went to a speaker training many years ago, in fact, this was around 2002 when Restasis came out, and it really, the panel did an excellent job of just really impressing upon the attendees that, you know, the quality of life scores of dry eye can really mimic, you know, even severe things like angina or disabling hip fracture. So, when I took that to heart, and I decided that it was time to come back to my practice and truly treat it like a disease. And so, I spent some time educating my key technicians, my team leader, and we actually carved out dedicated time just to really focus and concentrate on these patients. And what it did was, after they got to hear, you know, my walking the walk and talking the talk, you know, my dry eye practice really became more efficient because they knew what I was going to say before I was going to say it. And, but they truly developed appreciation for the fact that this is a disease. Whitney : Yeah. You raise a good point, you know, about the kind of parallels that are between more serious, as they would be noted, diseases and dry eye disease. I think that’s where a lot of the disconnect is. It’s not so much that the doctors don’t believe it exists. I think that most eyecare providers do. But it’s the gravity of it. So, the patient sitting across from them I think is oftentimes what’s missing. Rich : Yeah. Whitney : So, I think you probably latched onto that well in advance of a lot of our colleagues, including myself. So… Rich : Well, I’ve been around longer than you, Whitney. I’ve had a little bit of a head start in that respect. (laughs) Whitney : Unfortunately, not by as much as one would think. (laughs) You feel like this has a positive impact on new referrals as well? Bringing new patients into your practice? Rich : You know, it really does. Keep in mind, when I first started my dry eye practice I was in a co-management, a referral center, and one of the concerns we had when I brought this idea up was, how were our referring doctors going to look at this? Would they look at it like I was competing with them? And, in fact, the response was the complete opposite. They loved the fact that they had a resource in the area that really took this seriously. Patients could
Whitney Hauser : Hi, I’m Dr. Whitney Hauser and welcome to Dry Eye Coach podcast. Today I’m joined by Dr. Selina McGee. Selina is a private practitioner and owner of Precision Vision of Edmond and she’s also the president of the Oklahoma Association of Optometric Physicians. Welcome, Selina. How are you today? Selina McGee :I’m great. Thank you. Thank you for having me. Whitney Hauser :Good. I love that we both are on the line together talking and we’re both going to have accents, and we just say that right out of the gate. It’s so true. So hopefully the listeners will not need translators for this, but I love having that shared accent with you. We’re going to go ahead and get started. I’m just going to ask you a couple of questions and just to get your perspective on things, I think what’s interesting is a lot of experts in the field, particularly of dry eye, work in a lot of different areas. They work in tertiary dry centers, which I’ve been affiliated with. They work in ophthalmology practices. Some of them work in private practice, but we don’t hear quite as much of that voice. So I’m really anxious to kind of get your perspective on that today. The first question I’m going to jump in with is why, from your perspective, is patient education on dry eye so important? How does that fit into what you do with your patients every day? Selina McGee :It’s a great question, and I’m glad you led with the fact that I’m in private practice because I think honestly it makes so much sense in private practice, maybe even more so than in a tertiary setting or a co-management setting, simply because most patients don’t recognize their symptoms with dry eye disease and it affects every piece of private practice. What I mean by that is if you have an optical like I do, if you don’t treat their dry eye, they’re going to come back with a glasses RX check. We all know that time is money, and so when you spend that on a glasses RX check and in fact it’s ocular surface disease that we missed, then that’s a huge piece of that. Contact lens patients, lots of private practices have huge contact lens practices, mine included. So if we don’t do a good job of assessing the ocular surface and making sure that is stable, then your contact lens patients are going to suffer and you’re going to spend more chair time doing refits. Selina McGee :Then if you’re co-managing your surgical patients, and the patients that I work with and a lot of cataract patients these days, they have such good premium options. But if we don’t have a premium surface to deal with, once they get to the surgeon, they’re not going to have a premium outcome. Then of course in private practice, we have patients with glaucoma. We have patients that we’re the first line of defense. So if we don’t do a good job of [inaudible 00:03:06] and teaching our patients what dry eye disease looks like and what the symptoms are, then we can miss a lot of things including even something like a pass down of the disease of Sjogren’s. We know how dangerous that is because those patients unrecognized are much more likely to get lymphoma. So I think there’s such a huge opportunity for private practitioners to really embrace this and set themselves apart. Whitney Hauser :The education, as I asked that question was really kind of directed at how does education play a role with the patient directly? But really there’s almost two different ways that you can see that question. I think that you sort of embraced both angles of it, which is one, we’re educating the patient in dry eye disease about all the things that optometry can offer to them even if they’re not highly symptomatic. I think that’s an important piece because when you
Leveraging neuroscience to discover and develop novel therapies to treat ocular surface diseases For the show notes, full transcript, links, and resources please visit us at show link: https://bit.ly/2BrdYqu
This podcast is a short educational program for physicians and ophthalmologists on the topic of Dry Eye Disease.
Dr. Shay graduated with honors from the University of Pittsburgh in 2008, where she majored in Rehabilitation Science. In 2012, she received her Doctor of Optometry degree from Southern College of Optometry (Memphis, Tennessee). In addition to graduating at the top of her class, she was also honored to receive the SCO Outstanding Clinician Award. Dr Shay is highly skilled in full scope optometry and has extensive experience in the specialties of Glaucoma, Contact Lenses, Dry Eye Disease, and Pediatrics. Dr. Shay participates in the InfantSEE program, which provides a free eye exam to babies 6-12 months old. One of her passions is early detection of vision problems in children. As part of her training, she worked at Walter Reed National Military Medical Center where she had the opportunity to examine and treat soldiers with traumatic brain injuries. In 2018, Dr. Shay and Dr. Tim won the Hayes Center for Practice Excellence Award from their alma mater Southern College of Optometry for demonstrating excellence in private practice. Dr. Shay likes to travel, read, watch and play sports. She especially enjoys spending time with her husband, Dr. Tim, and their two daughters. For links to documents discussed in today's show click here!
2 interviews this week. In the first interview, Sean Henahan talks to José Güell, Associate Professor Ophthalmology, Autonoma University, Barcelona, Spain, about Ocular Surface Disease and the impact it has on surgical outcomes. In the second interview,Paul Rosen interviews Penny Asbell who says point-of-care testing may help ophthalmologists move forward to a more patient-centred approach in the diagnosis of Dry Eye Disease.
In one of the top episodes of Informed Consent, Marguerite McDonald, MD; Alan Carlson, MD; and Casey Claypool, OD, provide insight into how to educate patients about LipiFlow (Johnson & Johnson Vision) and when to introduce this treatment. Learn more about the importance of addressing dry eye disease early and not focusing solely on treating symptoms.
In one of the top episodes of Informed Consent, Marguerite McDonald, MD; Alan Carlson, MD; and Casey Claypool, OD, provide insight into how to educate patients about LipiFlow (Johnson & Johnson Vision) and when to introduce this treatment. Learn more about the importance of addressing dry eye disease early and not focusing solely on treating symptoms.
Whitney Hauser, OD, says that doctors don't need to invest in expensive technologies to start diagnosing and treating patients with dry eye symptoms. As doctors become more familiar with it and assess their community's need, they can scale up. Take me back to the Specialty Services cover story package.
She discusses where ocular surface disease has been historically and where it’s headed in the future. Listen as this dedicated clinician and researcher talks about her passion for dry eye and why you should share her enthusiasm.
Leveraging neuroscience to discover and develop novel therapies to treat ocular surface diseases
Jimmy and Roya give their thoughts on dealing with bad patient reviews and some unique patient situations. They also talk about amniotic membranes, rosacea and patient mental health.NOTESTopical/Oral Azithromycin vs. Doxycycline Outcomes Topical Azithromycin and Oral Doxycycline Therapy of Meibomian Gland Dysfunction: A Comparative Clinical and Spectroscopic Pilot Study, Cornea. 2013 Jan; 32(1): 44-53. Website: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138220/ Oral azithromycin versus doxycycline in meibomian gland dysfunction: a randomised double-masked open-label clinical trial. Br Jour Ophthal. 2015;99:199-204. Website: https://bjo.bmj.com/content/99/2/199.citation-tools DREAM Study: n−3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease. N Engl J Med 2018; 378:1681-1690. Website: https://www.nejm.org/doi/full/10.1056/NEJMoa1709691 Find a Therapist: This tool allows you to find a therapist for patient based on insurance, therapist specialty and location. www.Psychologytoday.com Review Facts: Physician Rating Websites: A Trend Worth Watching?: Insight MG. Website: https://insightmg.com/physician-rating-websites-a-trend-worth-watching/ Does Yelp Matter? http://snugdata.com/does-yelp-matter/ How Yelping Doctors Is Improving Americans’ Health Care: http://fortune.com/2017/04/23/health-care-yelp-zocdoc-healthgrades-doctor-reviews/
Marguerite McDonald, MD, invites Alan Carlson, MD, and Casey Claypool, OD, to the podcast to discuss the use of LipiFlow (Johnson & Johnson Vision) for the treatment of dry eye disease (DED). Drs. Carlson and Claypool share insights into how to educate patients about LipiFlow and when to introduce this treatment. Learn more about the importance of treating DED early, and not only focusing on treating symptoms.
Marguerite McDonald, MD, invites Alan Carlson, MD, and Casey Claypool, OD, to the podcast to discuss the use of LipiFlow (Johnson & Johnson Vision) for the treatment of dry eye disease (DED). Drs. Carlson and Claypool share insights into how to educate patients about LipiFlow and when to introduce this treatment. Learn more about the importance of treating DED early, and not only focusing on treating symptoms.
Dr Shane, Dr Euan and Chris KP bring you the week's hottest science! They chat about fake news, dinosaurs that dropped their tails, termites being reclassified as cockroaches, and shark populations in isolated areas of the Indian Ocean.They speak with Dr Laura Downie from the Downie Laboratory - Anterior Eye, Clinical Trials and Research Translation Unit, Faculty of Medicine, Dentistry and Health Sciences at the University of Melbourne, about her unit's research into improving the standards of eye care within the community. In particular, they discuss Dry Eye Disease.They also interview Kate Kenfield, Empathy Educator and Creator of ""Tea and Empathy"", from the School of Population and Global Health at the University of Melbourne, who is doing some very interesting work on training medicos, scientists etc in empathy.Remember, ""Science is everywhere"", including:Program page: Einstein A Go GoFacebook page: Einstein A Go GoTwitter: Einstein A Go Goand every Sunday at 11:00am AEST on RRR 102.7FM.
There are about 30 million adults in the U.S. who report symptoms consistent with dry eye. Leading expert Dr. Marguerite McDonald joins your award-winning family radio talk show Let's Talk America with Host Shana Thornton to discuss this growing health concern. Listen in with a friend. Thank you for visiting our page. Please visit www.ltaradio.com. #LTARadio
Three-year-old TearSolutions hopes to pen a strong sequel to SARCode’s successful tale of a start-up developing the next new treatment for Dry Eye Disease. Tom Gadek, co-founder of SARCode, developer of lifitegrast (now Shire’s potential blockbuster Xiidra), takes over the company as it begins courting partners and investors.
In this episode with Dr. Hauser we discuss the following subjects: What are dry eyes? Who has it and why? What are signs and symptoms? Is poorer eye health preventable or treatable? How you can help your eye’s performance in a blink of an eye What risks we can manage in day to day living to give our eyes a break, even when their closed The effects of contacts on our eyes health How to manage the good and bad days to keep a passion project moving in the right direction Dr. Whitney Hauser received her Doctor of Optometry degree in 2001 from Southern College of Optometry. She completed a postgraduate residency in Primary Care Optometry at the Southern College of Optometry. Prior to joining the SCO faculty, Dr. Hauser served as Clinical Director for an ophthalmology referral center in Memphis, Tennessee. During her ten years of practice, she not only served the needs of patients but also acted as research coordinator. Dr. Hauser co-authored several articles with a focus on the management and treatment of Dry Eye Disease. Dr. Hauser acted as adjunct faculty member at Southern College of Optometry from 2008-2013. Her areas of professional interest include Dry Eye Disease, surgical co-management, anterior segment disease and ocular nutrition.
TearScience CEO Tim Willis discusses the emergence of Dry Eye Disease and details how his company’s diagnostic and treatment for a source of the condition could help meet the increasing interest from physicians and patients.
© 2020-2025 Ivy Podcast Discovery LLC
